278 related articles for article (PubMed ID: 17889360)
1. Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
Isidori A; Motta MR; Tani M; Terragna C; Zinzani P; Curti A; Rizzi S; Taioli S; Giudice V; D'Addio A; Gugliotta G; Conte R; Baccarani M; Lemoli RM
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1224-32. PubMed ID: 17889360
[TBL] [Abstract][Full Text] [Related]
2. In vivo purging with rituximab prior to collection of stem cells for autologous transplantation in chronic lymphocytic leukemia.
Berkahn L; Simpson D; Raptis A; Klingemann HG
J Hematother Stem Cell Res; 2002 Apr; 11(2):315-20. PubMed ID: 11983102
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia.
Dreger P; Viehmann K; von Neuhoff N; Krüss D; Glass B; Kneba M; Mitsky P; Jopp P; Rautenberg P; Mills B; Schmitz N
Exp Hematol; 2000 Oct; 28(10):1187-96. PubMed ID: 11027838
[TBL] [Abstract][Full Text] [Related]
4. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
Bone Marrow Transplant; 1999 Jul; 24(2):153-61. PubMed ID: 10455343
[TBL] [Abstract][Full Text] [Related]
5. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
6. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
[TBL] [Abstract][Full Text] [Related]
7. Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia.
Koehl U; Zimmermann S; Esser R; Sörensen J; Grüttner HP; Duchscherer M; Seifried E; Klingebiel T; Schwabe D
Bone Marrow Transplant; 2002 Jun; 29(11):927-30. PubMed ID: 12080359
[TBL] [Abstract][Full Text] [Related]
8. Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells.
Gordon PR; Leimig T; Babarin-Dorner A; Houston J; Holladay M; Mueller I; Geiger T; Handgretinger R
Bone Marrow Transplant; 2003 Jan; 31(1):17-22. PubMed ID: 12621502
[TBL] [Abstract][Full Text] [Related]
9. CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation.
Jaime-Pérez JC; Guillermo-Villanueva VA; Méndez-Ramírez N; Chapa-Rodríguez A; Gutiérrez-Aguirre H; Gómez-Almaguer D
Transfusion; 2009 Nov; 49(11):2390-4. PubMed ID: 19903294
[TBL] [Abstract][Full Text] [Related]
10. Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma.
Lemoli RM; Fortuna A; Raspadori D; Ventura MA; Martinelli G; Gozzetti A; Leopardi G; Ratta M; Cavo M; Tura S
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():1-11. PubMed ID: 9570675
[TBL] [Abstract][Full Text] [Related]
11. Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL.
Paulus U; Schmitz N; Viehmann K; von Neuhoff N; Dreger P
Bone Marrow Transplant; 1997 Sep; 20(5):415-20. PubMed ID: 9339759
[TBL] [Abstract][Full Text] [Related]
12. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.
Lang P; Schumm M; Greil J; Bader P; Klingebiel T; Müller I; Feuchtinger T; Pfeiffer M; Schlegel PG; Niethammer D; Handgretinger R
Klin Padiatr; 2005; 217(6):334-8. PubMed ID: 16307419
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of purified autologous leukapheresis-derived CD34+ and CD133+ stem cells for patients with chronic spinal cord injuries: long-term evaluation of safety and efficacy.
Al-Zoubi A; Jafar E; Jamous M; Al-Twal F; Al-Bakheet S; Zalloum M; Khalifeh F; Radi SA; El-Khateeb M; Al-Zoubi Z
Cell Transplant; 2014; 23 Suppl 1():S25-34. PubMed ID: 25372344
[TBL] [Abstract][Full Text] [Related]
14. CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device.
Després D; Flohr T; Uppenkamp M; Baldus M; Hoffmann M; Huber C; Derigs HG
J Hematother Stem Cell Res; 2000 Aug; 9(4):557-64. PubMed ID: 10982256
[TBL] [Abstract][Full Text] [Related]
15. Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma.
Webb IJ; Friedberg nW; Gribben JG; Fisher DC; Spitzer T; Neuberg D; Jallow H; Kim H; Houde H; Monroy R; Schmittling R; Freedman AS
Biol Blood Marrow Transplant; 2002; 8(8):429-34. PubMed ID: 12234168
[TBL] [Abstract][Full Text] [Related]
16. PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia.
Scimè R; Indovina A; Santoro A; Musso M; Olivieri A; Tringali S; Crescimanno A; Montanari M; Felice R; Catania P; Mariani G; Leoni P; Majolino I
Bone Marrow Transplant; 1998 Dec; 22(12):1159-65. PubMed ID: 9894718
[TBL] [Abstract][Full Text] [Related]
17. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
[TBL] [Abstract][Full Text] [Related]
18. Mobilization kinetics of CD133+ hematoprogenitor cells for hematopoietic grafting.
Jaime-Pérez JC; Hernández-Alcántara AE; Méndez-Ramírez N; Vázquez-Garza E; Cantú-Rodríguez OG; Gómez-Almaguer D
Transfusion; 2009 Mar; 49(3):532-5. PubMed ID: 19243545
[TBL] [Abstract][Full Text] [Related]
19. Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial.
Andreone P; Catani L; Margini C; Brodosi L; Lorenzini S; Sollazzo D; Nicolini B; Giordano R; Montemurro T; Rizzi S; Dan E; Giudice V; Viganò M; Casadei A; Foschi FG; Malvi D; Bernardi M; Conti F; Lemoli RM
Dig Liver Dis; 2015 Dec; 47(12):1059-66. PubMed ID: 26427587
[TBL] [Abstract][Full Text] [Related]
20. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
Lemoli RM; Fortuna A; Motta MR; Rizzi S; Giudice V; Nannetti A; Martinelli G; Cavo M; Amabile M; Mangianti S; Fogli M; Conte R; Tura S
Blood; 1996 Feb; 87(4):1625-34. PubMed ID: 8608257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]